Skip to main content

Table 2 Results of bias risk assessment (Score)

From: Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis

 

Name

Selection

Comparability

Outcome

Score

Quality Grade

1

Akalu TY

1

1

1

0

2

1

1

1

8

High quality

2

Akinsola OJ

1

1

1

0

2

1

1

1

8

High quality

3

Putri FA

1

1

1

0

2

0

1

1

7

Moderate quality

4

Lu P

1

1

1

1

2

1

1

1

9

High quality

5

Li Q

1

1

1

0

2

1

1

1

8

High quality

6

Kurbatova EV

1

1

1

0

2

1

1

1

8

High quality

7

Li Q

1

1

1

0

2

1

1

1

8

High quality

8

Liu Q

1

1

1

1

2

1

1

1

9

High quality

9

Magee MJ

1

1

1

1

2

1

1

1

9

High quality

10

Ncha R

1

1

1

0

2

1

1

1

8

High quality

11

Mpagama SG

1

1

1

0

2

0

1

1

7

Moderate quality

12

Huerga H

1

1

1

0

2

1

1

1

8

High quality

13

Bade AB

1

1

1

1

2

0

1

1

8

High quality

14

Brust JC

1

1

1

0

1

1

1

1

7

Moderate quality

15

Magee MJ

1

1

1

1

2

1

1

1

9

High quality

16

Brust JC

1

1

1

0

2

1

1

1

8

High quality

17

Gadallah MA

1

1

1

1

2

1

1

1

9

High quality

18

Zheng X

1

1

1

1

2

1

1

1

9

High quality

19

Tierney DB

1

1

1

0

2

0

1

1

7

Moderate quality

20

Lee M

1

1

1

0

2

1

0

1

7

Moderate quality

21

Javaid A

1

1

1

0

2

1

1

1

8

High quality

22

Hafkin J

1

1

1

0

2

0

0

1

6

Moderate quality

23

Ghimire S

1

1

1

0

2

1

1

1

8

High quality

24

Diktanas S

1

1

1

0

2

1

1

1

8

High quality

25

Meshesha MD

1

1

1

0

2

0

0

1

6

Moderate quality

26

Tekalegn Y

1

1

1

0

2

1

1

1

8

High quality

27

Velayutham B

1

1

1

0

2

1

1

1

8

High quality

28

Diallo A

1

1

1

0

2

1

1

1

8

High quality

29

Reimann M

1

1

1

0

2

1

0

1

7

Moderate quality

30

Shibabaw A

1

1

1

0

2

1

0

1

7

Moderate quality

31

Ding CH

1

1

1

1

2

1

1

1

9

High quality

32

Htun YM

1

1

1

0

2

1

1

1

8

High quality

33

Shi ZY

1

1

1

1

2

1

1

1

9

High quality

34

Kim CT

1

1

1

0

1

1

0

1

6

Moderate quality

35

Abubakar M

1

1

1

0

2

1

0

1

7

Moderate quality

36

Salindri AD

1

1

1

1

2

1

1

1

9

High quality

37

Wu GL

1

1

1

1

0

1

1

1

8

High quality

38

Pei Y

1

1

1

1

1

1

1

1

8

High quality

39

Kim J

1

1

1

0

2

1

0

1

7

Moderate quality

40

Shi L

1

1

1

0

2

1

1

1

8

High quality

41

Rodriguez M

1

1

1

0

2

1

1

1

8

High quality

42

Parmar MM

1

1

1

0

2

1

1

1

7

Moderate quality

43

Heyckendorf J

1

1

1

1

2

1

1

1

9

High quality

44

Gao M

1

1

1

1

2

1

1

1

9

High quality

45

Borisov SE

1

1

1

0

2

1

1

1

8

High quality

  1. Note: Representativeness of the exposed cohort; selection of the non exposed cohort; Ascertainment of exposure; Demonstration that outcome of interest was not present at start of study; Comparability of cohorts on the basis of the design or analysis; Assessment of outcome; Was follow-up long enough for outcomes to occur; Adequacy of follow up of cohorts